Ceylon cinnamon supplement for people with painful diabetic nerve damage
Tests Ceylon cinnamon capsules against placebo in adults with painful diabetic peripheral neuropathy.
Key facts
- Who runs it
- JAWAD AHMAD ABU-SHENNAR
- Where
- Jordan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- The Effects of Ceylon Cinnamon (Cinnamomum Verum) Supplementation on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Intensity Among Adult Individuals With Painful Diabetic Peripheral Neuropathy
- Status
- Recruiting
- People taking part
- 164 people, planned
- Started
- 1 Feb 2026
- Planned end
- 30 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Ceylon Cinnamon Supplement
- Record updated
- 3 August 2026
Who can take part
The trial is looking for adults with type 2 diabetes who have painful nerve damage in the feet or hands caused by diabetes (painful diabetic peripheral neuropathy).
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Painful diabetic peripheral neuropathy (PDPN) with documented type 2 diabetes (T2DM)
- Earlier treatment
- People cannot join if they take medicines that could affect blood sugar control or pain, such as systemic glucocorticoids, weight-loss agents, or iron and vitamin B12 supplements.
- Main reasons for not taking part
- Chronic kidney disease (CKD)
- High blood pressure (hypertension)
- Heart or blood vessel disease (CVD)
- Problems with thinking or senses, such as reading or hearing difficulties
- Taking systemic glucocorticoids, weight-loss agents, or iron or vitamin B12 supplements
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Age ≥ 18years diagnosed with PDPN
- With documented T2DM
Who cannot take part
- If they had coexisting chronic conditions, including chronic kidney disease (CKD), hypertension, cardiovascular disease (CVD), or cognitive/sensory impairments (e.g., reading or hearing difficulties)
- individuals receiving medications that could confound blood glucose control or pain perception (such as systemic glucocorticoids, weight-loss agents, or iron and vitamin B12 supplements)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Painful diabetic peripheral neuropathy
This trial is currently available in Jordan.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: Painful diabetic peripheral neuropathy (PDPN) is a severe, disabling complication of type 2 diabetes mellitus (T2DM), closely associated with insulin resistance, chronic neuroinflammation, and oxidative stress. Plant-based dietary supplements, particularly Ceylon cinnamon (Cinnamomum verum), contain bioactive compounds with potential anti-diabetic, antioxidant, and neuroprotective properties.
Read full original descriptionShow less
Aim: To evaluate the effects of Ceylon Cinnamon (Cinnamomum verum) supplementation on blood glucose, lipid profile levels, body mass index (BMI), and pain intensity among adult individuals with painful diabetic peripheral neuropathy (PDPN).
Methods: A prospective, double-blind, randomized controlled trial (Double-Blind RCT) was conducted (Feb-July 2026) across endocrinology outpatient clinics in Jordan. Participants were randomly allocated in a 1:1 ratio to either the Intervention Group (n = 62; 500 mg Ceylon cinnamon twice daily for 6 months alongside standard care) or the Placebo Control Group (n = 62; 500 mg placebo capsules twice daily for 6 months alongside standard care). Clinical, biochemical, and pain assessments (using the Numeric Rating Scale [NRS]) were evaluated at baseline, 3 months, and 6 months post-intervention.
The 2 groups in the trial
- Ceylon Cinnamon GroupTreatment being tested
Participants receive Ceylon Cinnamon supplementation daily for a specified duration.
Treatment: Ceylon Cinnamon Supplement
- Control GroupPlacebo, for comparison
Participants receive a matching placebo daily for the same duration.
Treatment: Ceylon Cinnamon Supplement
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Ceylon Cinnamon (Cinnamomum Verum) Supplementation on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Intensity Among Adult Individuals With Painful Diabetic Peripheral Neuropathy: A Double-Blind Randomized Controlled Trial
- Plain-language title
- Ceylon cinnamon supplement for people with painful diabetic nerve damageGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07743073, who can take part
- Record updated
- 3 August 2026